查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611911

3D 列印製药市场：按技术、剂型、应用、最终用户划分 - 全球预测 2025-2030

3D Printed Drugs Market by Technology (Direct-Write, Fused Deposition Modelling, Inkjet Printing), Dose Form (Capsule, Nanoparticles, Tablet), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年3D列印药品市值为2.9272亿美元，预计到2024年将达到3.3122亿美元，复合年增长率为14.26%，到2030年将达到7.4429亿美元。

3D列印药物市场是製药业的一个创新领域，旨在透过利用赋形剂製造技术来创造个人化药物，从而彻底改变药物製造。对3D列印药品的需求源于对患者特定药物日益增长的需求，这些药物的剂量、剂型和成分可以定制，以有效满足个人健康需求。 3D列印药物的应用范围包括慢性病管理、老年护理、小儿科等。最终用途包括医院、製药公司和研究机构，所有这些都需要高效、经济高效和客製化的药品製造能力。

主要市场统计
基准年[2023] 2.9272亿美元
预计年份 [2024] 33122万美元
预测年份 [2030] 74429万美元
复合年增长率（%） 14.26%

市场的关键成长要素包括技术进步、慢性病的增加以及卫生当局对个人化医疗的监管支持。减少药物浪费和提高患者依从性的潜力正在进一步推动该市场的扩张。透过利用与医疗保健提供者的伙伴关係关係并投资于研发，有机会使用 3D 列印技术来开发有效且易于製造的新型药物配方。然而，高昂的初始成本、技术限制和严格的监管要求等挑战可能会阻碍市场成长。此外，医疗保健提供者缺乏广泛的认可和接受也是一个额外的障碍。

具有巨大潜力的创新研发领域包括开发用于药物列印的生物相容性和生物分解性材料、提高印表机的速度和精度以及透过3D列印实现剂型多样化。透过专注于这些创新并培养策略联盟来加强我们的市场影响力和基础设施，可以实现业务成长。市场的本质是动态的，其特点是快速的技术创新和对精准医疗的日益重视。透过建立强大的分销网络并参与持续的相关人员教育计划，公司可以倡导放宽限制并将 3D 列印药物纳入主流医疗保健实践。

市场动态：揭示快速发展的 3D 列印製药市场的关键市场洞察

供需的动态交互作用正在改变 3D 列印製药市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对速溶药物的需求迅速成长
    • 扩大个人化药物的采用和生产组合药物
    • 扩大3D列印技术在抗癌药物生产的应用
  • 市场限制因素
    • 与 3D 列印药品製造相关的材料限制
  • 市场机会
    • 3D列印技术持续技术发展
    • 3D列印药物製造的重大投资
  • 市场挑战
    • 3D 列印药品製造的复杂性

波特五力：驾驭 3D 列印製药市场的策略工具

波特的五力架构是了解 3D 列印药品市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解 3D 列印製药市场的外部影响

外部宏观环境因素在塑造 3D 列印药品市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解3D列印医药市场竞争状况

对 3D 列印药品市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 3D 列印药品市场供应商的绩效评估

FPNV 定位矩阵是评估 3D 列印药品市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了 3D 列印药品市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 3D 列印药品市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对速效药物的需求迅速增加
      • 扩大个人化药物的采用和复杂药物的生产
      • 广泛利用3D列印技术製造癌症治疗药物
    • 抑制因素
      • 与 3D 列印药品製造相关的材料限制
    • 机会
      • 3D列印技术持续技术发展
      • 大量投资生产 3D 列印药品
    • 任务
      • 3D 列印药品製造的复杂性
  • 市场区隔分析
    • 技术：直写技术提供个人化、有效的剂量解决方案
    • 剂型：可采用胶囊形式的 3D 列印药物
    • 应用：扩大在神经系统药物製造的应用
    • 最终用户：3D列印药品在诊所和医院的渗透率较高
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 3D 列印药品市场：依技术分类

  • 直接写入
  • 熔融沈积法
  • 喷墨印刷
  • 粉红床印刷
  • 立体光刻技术
  • 拉炼剂量

第七章依剂型分類的3D列印药品市场

  • 胶囊
  • 奈米粒子
  • 锭剂

第8章 3D列印医药市场：依应用分类

  • 牙科
  • 神经病学
  • 整形外科

第 9 章 3D 列印製药市场：依最终用户分类

  • 诊所和医院
  • 研究室
  • 专科诊所

第10章美洲3D列印药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区3D列印医药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲3D列印药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Triastek 和 BioNTech 合作开发口服 3D 列印 RNA 疗法，目标是超过 12 亿美元的里程碑付款
    • Carsinotech筹集420万英镑进军美国，推动个人化肿瘤药物开发的3D列印微肿瘤技术
    • CurifyLabs 推出个人化医疗 3D 列印解决方案
    • Cellink 和 Carcinotech 合作透过 3D 生物列印转变癌症药物开发
    • Triastek 的 3D 列印药物治疗溃疡性大肠炎获得 FDA IND核准
  • 战略分析和建议

公司名单

  • 3D Systems, Inc.
  • 3DR HOLDINGS
  • Anatomics Pty Ltd
  • Aprecia Pharmaceuticals, LLC
  • AstraZeneca plc
  • BioDuro, LLC
  • Biomedical Modeling Inc.
  • Cycle Pharmaceuticals
  • Cyfuse Biomedical KK
  • EnvisionTEC GmbH
  • FabRx Ltd.
  • General Electric Company
  • GlaxoSmithKline Plc
  • Materialise NV
  • Merck KGaA
  • Organovo Holdings Inc.
  • Proto Labs Inc.
  • Renishaw PLC
  • Rokit Healthcare Inc.
  • Siemens AG
  • Stratasys Ltd.
  • Triastek, Inc.
  • TVASTA
  • Yissum
  • Zortrax SA
Product Code: MRR-431C35F6C179

The 3D Printed Drugs Market was valued at USD 292.72 million in 2023, expected to reach USD 331.22 million in 2024, and is projected to grow at a CAGR of 14.26%, to USD 744.29 million by 2030.

The 3D printed drugs market is an innovative segment in the pharmaceutical industry that aims to revolutionize drug manufacturing by utilizing additive manufacturing techniques to create personalized medication. The need for 3D printed drugs arises from the growing demand for patient-specific medication that can adjust dosages, forms, and compositions to meet individual health requirements effectively. Applications of 3D printed drugs span across chronic disease management, elder care, and pediatrics, where tailored dosages are crucial. The end-use scope includes hospitals, pharmaceutical companies, and research institutions, all seeking efficient, cost-effective, and customized drug production capabilities.

KEY MARKET STATISTICS
Base Year [2023] USD 292.72 million
Estimated Year [2024] USD 331.22 million
Forecast Year [2030] USD 744.29 million
CAGR (%) 14.26%

Key growth factors in this market include technological advancements, the increasing incidence of chronic diseases, and regulatory support from health authorities for personalized medicine. The potential to reduce drug wastage and enhance patient compliance further augments this market's expansion. Opportunities lie in leveraging partnerships with healthcare providers and investing in R&D to develop novel drug formulations that are both efficacious and easy to produce using 3D printing technology. However, challenges such as high initial costs, technical limitations, and stringent regulatory requirements could impede market growth. Additionally, the lack of widespread awareness and acceptance among healthcare providers poses further hurdles.

Innovative research areas with significant potential include developing biocompatible and biodegradable materials for drug printing, enhancing printer speed and precision, and creating a wider array of 3D printed dosage forms. Business growth can be realized by focusing on these technological innovations and fostering strategic alliances that bolster market presence and infrastructure. The nature of the market is dynamic, characterized by rapid technological changes and a growing emphasis on precision medicine. Companies might benefit from developing robust distribution networks and engaging in continuous education initiatives for stakeholders to mitigate limitations and advocate for the integration of 3D printed drugs in mainstream healthcare practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving 3D Printed Drugs Market

The 3D Printed Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in demand for instantaneous soluble drugs
    • Growing adoption of personalized drugs and the production of combination medicine
    • Extensive use of 3D printed technology for manufacturing cancer drugs
  • Market Restraints
    • Material limitations associated with manufacturing of 3D printed drugs
  • Market Opportunities
    • Constant technological developments in 3D printing technique
    • Significant investments for manufacturing of 3D printed pharmaceuticals
  • Market Challenges
    • Complexities in manufacturing of 3D printed drugs

Porter's Five Forces: A Strategic Tool for Navigating the 3D Printed Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the 3D Printed Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the 3D Printed Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the 3D Printed Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the 3D Printed Drugs Market

A detailed market share analysis in the 3D Printed Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the 3D Printed Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the 3D Printed Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the 3D Printed Drugs Market

A strategic analysis of the 3D Printed Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the 3D Printed Drugs Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., 3DR HOLDINGS, Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, AstraZeneca plc, BioDuro, LLC, Biomedical Modeling Inc., Cycle Pharmaceuticals, Cyfuse Biomedical K.K., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, GlaxoSmithKline Plc, Materialise NV, Merck KGaA, Organovo Holdings Inc., Proto Labs Inc., Renishaw PLC, Rokit Healthcare Inc., Siemens AG, Stratasys Ltd., Triastek, Inc., TVASTA, Yissum, and Zortrax S.A..

Market Segmentation & Coverage

This research report categorizes the 3D Printed Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Direct-Write, Fused Deposition Modelling, Inkjet Printing, Powder Bed Printing, Stereolithography, and Zip Dose.
  • Based on Dose Form, market is studied across Capsule, Nanoparticles, and Tablet.
  • Based on Application, market is studied across Dental, Neurology, and Orthopedic.
  • Based on End-User, market is studied across Clinics & Hospitals, Research Laboratories, and Speciality Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in demand for instantaneous soluble drugs
      • 5.1.1.2. Growing adoption of personalized drugs and the production of combination medicine
      • 5.1.1.3. Extensive use of 3D printed technology for manufacturing cancer drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Material limitations associated with manufacturing of 3D printed drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Constant technological developments in 3D printing technique
      • 5.1.3.2. Significant investments for manufacturing of 3D printed pharmaceuticals
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities in manufacturing of 3D printed drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Direct-write technology provides personalized and effective medication solutions
    • 5.2.2. Dose Form: Potential adoption of 3D printed drugs in the form of capsule
    • 5.2.3. Application: Proliferating use for manufacturing of neurology drugs
    • 5.2.4. End-User: Significant penetration of 3D printed drugs in clinics & hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. 3D Printed Drugs Market, by Technology

  • 6.1. Introduction
  • 6.2. Direct-Write
  • 6.3. Fused Deposition Modelling
  • 6.4. Inkjet Printing
  • 6.5. Powder Bed Printing
  • 6.6. Stereolithography
  • 6.7. Zip Dose

7. 3D Printed Drugs Market, by Dose Form

  • 7.1. Introduction
  • 7.2. Capsule
  • 7.3. Nanoparticles
  • 7.4. Tablet

8. 3D Printed Drugs Market, by Application

  • 8.1. Introduction
  • 8.2. Dental
  • 8.3. Neurology
  • 8.4. Orthopedic

9. 3D Printed Drugs Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinics & Hospitals
  • 9.3. Research Laboratories
  • 9.4. Speciality Clinics

10. Americas 3D Printed Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific 3D Printed Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa 3D Printed Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Triastek and BioNTech partner to develop 3D printed RNA therapeutics for oral delivery, aiming for over USD 1.2 billion in milestone payments
    • 13.3.2. Carcinotech raises GBP 4.2 million for US expansion, enhancing 3D-printed micro-tumour tech for personalized oncology drug development
    • 13.3.3. CurifyLabs Launches 3D Printing Solution For Personalised Medicine
    • 13.3.4. Cellink And Carcinotech Partner To Transform Cancer Drug Development With 3d Bioprinting
    • 13.3.5. Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3D Systems, Inc.
  • 2. 3DR HOLDINGS
  • 3. Anatomics Pty Ltd
  • 4. Aprecia Pharmaceuticals, LLC
  • 5. AstraZeneca plc
  • 6. BioDuro, LLC
  • 7. Biomedical Modeling Inc.
  • 8. Cycle Pharmaceuticals
  • 9. Cyfuse Biomedical K.K.
  • 10. EnvisionTEC GmbH
  • 11. FabRx Ltd.
  • 12. General Electric Company
  • 13. GlaxoSmithKline Plc
  • 14. Materialise NV
  • 15. Merck KGaA
  • 16. Organovo Holdings Inc.
  • 17. Proto Labs Inc.
  • 18. Renishaw PLC
  • 19. Rokit Healthcare Inc.
  • 20. Siemens AG
  • 21. Stratasys Ltd.
  • 22. Triastek, Inc.
  • 23. TVASTA
  • 24. Yissum
  • 25. Zortrax S.A.

LIST OF FIGURES

  • FIGURE 1. 3D PRINTED DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. 3D PRINTED DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. 3D PRINTED DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. 3D PRINTED DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY DOSE FORM, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. 3D PRINTED DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. 3D PRINTED DRUGS MARKET, FPNV POSITIONING MATRIX, 2023